Skip to main content

Advertisement

SpringerLink
Log in

Residual Breast Tissue after Mastectomy: How Often and Where Is It Located?

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Residual breast tissue after a mastectomy can lead to a (second) primary breast cancer. The development of breast cancer after prophylactic mastectomy and the finding of normal breast tissue around a local recurrence support this assumption. The aim of the present study was to investigate the prevalence and localization of residual breast tissue after a mastectomy.

Methods

A series of 206 women who underwent a mastectomy between January 2008 and August 2009 in 11 hospitals were enrolled onto this study after written informed consent was obtained. From each mastectomy specimen, a total of 36 samples were obtained from the superficial dissection plane at predetermined locations. The biopsy samples were analyzed for the presence of benign breast tissue in the inked superficial area. Differences in percentage of positive samples were analyzed by generalized estimating equations to account for their interdependence.

Results

A total of 7,374 biopsy samples from 206 breast specimens of 206 patients were included in the analysis. In 76.2 % of the specimens (n = 157), one or more positive biopsy samples were found. The positive findings were found diffusely across the superficial dissection surface of the specimen with a significant predilection for the lower outer quadrant and the middle circle of the superficial dissection plane.

Conclusions

After a mastectomy, there is a high probability of residual breast tissue. This tissue is predominantly located in the middle circle of the superficial dissection plane and in the lower outer quadrant. Surgeons should be aware of these locations so they may remove as much of the benign breast tissue as possible.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

FIG. 1
FIG. 2
FIG. 3

Similar content being viewed by others

REFERENCES

  1. Oncoline: cancer clinical practice guidelines. http://www.oncoline.nl. Version 2.0. Consensus based 13 Feb 2012.

  2. Willemsen HW, Kaas R, Peterse JH, Rutgers EJ. Breast carcinoma in residual breast tissue after prophylactic bilateral subcutaneous mastectomy. Eur J Surg Oncol. 1998;24:331–2.

    Article  CAS  PubMed  Google Scholar 

  3. Goodnight JE Jr, Quagliana JM, Morton DL. Failure of subcutaneous mastectomy to prevent the development of breast cancer. J Surg Oncol. 1984;26:190–201.

    Article  Google Scholar 

  4. Eldar S, Meguid MM. Beatty JD. Cancer of the breast after prophylactic subcutaneous mastectomy. Am J Surg. 1984;148:692–3.

    Article  CAS  PubMed  Google Scholar 

  5. Pennisi VR, Capozzi A. Subcutaneous mastectomy data: a final statistical analysis of 1500 patients. Aesthetic Plast Surg. 1989;13:15–21.

    Article  CAS  PubMed  Google Scholar 

  6. Ziegler LD, Kroll SS. Primary breast cancer after prophylactic mastectomy. Am J Clin Oncol. 1991;14:451–4.

    CAS  PubMed  Google Scholar 

  7. Lostumbo L, Carbine N, Wallace l. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev. 2010;(11):CD002748.

  8. Hartmann LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med. 1999;340:77–84.

    Article  CAS  PubMed  Google Scholar 

  9. Meijers-Heijboer H, van Geel B, van Putten WL, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2001;345:159–64.

    Article  CAS  PubMed  Google Scholar 

  10. Rebbeck TR, Friebel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol. 2004;22:1055–62.

    Article  PubMed  Google Scholar 

  11. Heemskerk-Gerritsen BA, Brekelmans CT, Menke-Pluymers MB, et al. Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experience at the Rotterdam Family Cancer Clinic. Ann Surg Oncol. 2007;14:3335–44.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Sacchini V, Pinotti JA, Barros AC, et al. Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem? J Am Coll Surg. 2006;203:704–14.

    Article  PubMed  Google Scholar 

  13. Cao D, Tsangaris TN, Kouprina N, et al. The superficial margin of the skin-sparing mastectomy for breast carcinoma: factors predicting involvement and efficacy of additional margin sampling. Ann Surg Oncol. 2008;15:1330–40.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Simmons RM, Fish SK, Gayle L, et al. Local and distant recurrence rates in skin-sparing mastectomies compared with non–skin sparing mastectomies. Ann Surg Oncol. 1999;6:676–81.

    Article  CAS  PubMed  Google Scholar 

  15. Carlson GW, Styblo TM, Lyles RH, et al. Local recurrence after skin-sparing mastectomy: tumor biology or surgical conservatism? Ann Surg Oncol. 2003;10:108–12.

    Article  PubMed  Google Scholar 

  16. Kroll SS, Khoo A, Singletary SE, et al. Local recurrence risk after skin-sparing and conventional mastectomy: a 6-year follow-up. Plast Reconstr Surg. 1999;104:421–5.

    Article  CAS  PubMed  Google Scholar 

  17. Medina-Franco H, Vasconez LO, Fix RJ, et al. Factors associated with local recurrence after skin-sparing mastectomy and immediate breast reconstruction for invasive breast cancer. Ann Surg. 2002;235:814–9.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Newman LA, Kuerer HM, Hunt KK, et al. Presentation, treatment, and outcome of local recurrence after skin-sparing mastectomy and immediate breast reconstruction. Ann Surg Oncol. 1998;5:620–6.

    Article  CAS  PubMed  Google Scholar 

  19. Patani N, Mokbel K. Oncological and aesthetic considerations of skin-sparing mastectomy. Breast Cancer Res Treat. 2008;111:391–403.

    Article  PubMed  Google Scholar 

  20. Simmons RM, Adamovich TL. Skin-sparing mastectomy. Surg Clin North Am. 2003;83:885–99.

    Article  PubMed  Google Scholar 

  21. Singletary SE, Kroll SS. Skin-sparing mastectomy with immediate breast reconstruction. Adv Surg. 1996;30:39–52.

    CAS  PubMed  Google Scholar 

  22. Rivadeneira DE, Simmons RM, Fish SK, et al. Skin-sparing mastectomy with immediate breast reconstruction: a critical analysis of local recurrence. Cancer J. 2000;6:331–5.

    CAS  PubMed  Google Scholar 

  23. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–106.

    Article  CAS  PubMed  Google Scholar 

  24. Vaughan A, Dietz JR, Aft A, et al. Patterns of local breast cancer recurrence after skin-sparing mastectomy and immediate reconstruction. Am J Surg. 2007;194:438–43.

    Article  PubMed  Google Scholar 

  25. Kim JH, Tavassoli F, Haffty BG. Chest wall relapse after mastectomy for ductal carcinoma in situ: a report of 10 cases with a review of the literature. Cancer J. 2006;12:92–101.

    PubMed  Google Scholar 

  26. Hicken NF. Mastectomy. Clinical pathologic study demonstrating why most mastectomies result in incomplete removal of the mammary gland. Arch Surg. 1940;40:6–14.

    Article  Google Scholar 

  27. Goldman LD, Goldwyn RM. Some anatomical considerations of subcutaneous mastectomy. Plast Reconstr Surg. 1973;51:501–5.

    Article  CAS  PubMed  Google Scholar 

  28. Temple WJ. Lindsay RL, Magi E, Urbanski SJ. Technical considerations for prophylactic mastectomy in patients at high risk for breast cancer. Am J Surg. 1991;161:413–5.

    Article  CAS  PubMed  Google Scholar 

  29. Barton FE Jr, English JM, Kingsley WB, Fietz M. Glandular excision in total glandular mastectomy and modified radical mastectomy: a comparison. Plast Reconstr Surg. 1991;88:389–92.

    Article  PubMed  Google Scholar 

  30. Tewari M, Kumar K, Kumar M, Shukla HS. Residual breast tissue in the skin flaps after Patey mastectomy. Indian J Med Res. 2004;119:195–7.

    PubMed  Google Scholar 

  31. Torresan RZ, dos Santos CC, Okamura H, Alvarenga M. Evaluation of residual glandular tissue after skin-sparing mastectomies. Ann Surg Oncol. 2005;12:1037–44.

    Article  PubMed  Google Scholar 

  32. Beer GM, Varga Z, Budi S, Seifert B, Meyer VE. Incidence of the superficial fascia and its relevance in skin-sparing mastectomy. Cancer. 2002;94:1619–25.

    Article  PubMed  Google Scholar 

  33. de Bock GH, van der Hage JA, Putter H, Bonnema J, Bartelink H, van de Velde CJ. Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organization for Research and Treatment of Cancer studies. Eur J Cancer. 2006;42:351–6.

    Article  PubMed  Google Scholar 

Download references

ACKNOWLEDGMENT

The authors thank all included patients. The authors thank all breast surgeons and nurse practitioners from the participating hospitals: Medical Centre Leeuwarden; Tjongerschans Hospital, Heerenveen; Nij Smellinghe Hospital, Drachten; Antonius Hospital Sneek; Sionsberg Hospital, Dokkum; Martini Hospital, Groningen; Isala Clinics, Zwolle; Wilhelmina Hospital Assen; Diaconessenhuis, Meppel; Bethesda Hospital, Hoogeveen; Röpke-Zwiers Hospital, Hardenberg. The authors thank James Collins, radiologist, for the English-language version of the article and Liesbeth Jansen, surgical oncologist, for help with revision.

DISCLOSURE

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

    M. Griepsma MSc

  2. Department of Surgery, Medical Center Leeuwarden, Leeuwarden, The Netherlands

    D. B. W. de Roy van Zuidewijn MD, PhD

  3. Pathology Friesland, Leeuwarden, The Netherlands

    A. J. K. Grond MD, PhD

  4. Department of Research and Registration, Comprehensive Cancer Centre The Netherlands, Utrecht, The Netherlands

    S. Siesling PhD

  5. Department of Health Technology and Services Research, MIRA Institute of Technical Medicine and Biomedical Technology, University of Twente, Enschede, The Netherlands

    S. Siesling PhD

  6. Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

    H. Groen MD, PhD & G. H. de Bock

Authors
  1. M. Griepsma MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. B. W. de Roy van Zuidewijn MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. J. K. Grond MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Siesling PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Groen MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. H. de Bock
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. B. W. de Roy van Zuidewijn MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Griepsma, M., de Roy van Zuidewijn, D.B.W., Grond, A.J.K. et al. Residual Breast Tissue after Mastectomy: How Often and Where Is It Located?. Ann Surg Oncol 21, 1260–1266 (2014). https://doi.org/10.1245/s10434-013-3383-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-013-3383-x

Keywords

Search

Navigation